Earnings Report·May 11, 2026
STERIS (NYSE: STE) Reports Fiscal Q4 Beat; Stock Falls Despite Earnings Surprise
STERIS beat EPS estimates in fiscal Q4 but shares declined 2.70% as investors weighed the results on Monday.
STERIS plc (NYSE: STE) Stock News & Analysis
STERIS plc (NYSE: STE) is a healthcare company, listed on the NYSE. Alpha Stocks Insight tracks STE across all major catalysts: quarterly earnings reports, analyst upgrades and downgrades, mergers and acquisitions, regulatory decisions, and significant price moves driven by sector or macro developments. This page centralises 2 articles published since May 11, 2026, providing investors with timely, data-driven analysis of STERIS plc's financial performance and competitive position. New coverage is added each trading day.
STE Coverage -- 2 Articles
Earnings Report·May 12, 2026
STERIS (NYSE: STE) Rebounds 4.46% Despite Q4 Miss on Earnings and Revenue
STERIS stock surged on Tuesday, May 12, even after reporting Q4 results that fell short of consensus expectations.
3 min readRead article
Important Legal Disclaimer
This is for informational purposes only and is not financial, investment, or tax advice. Past performance is no guarantee of future results. We are not licensed advisors. For Swiss residents: This does not constitute a public offer under FINSA. For EU residents: Not MiFID II compliant advice. For US residents: Not SEC-registered advice. Always consult a qualified professional. Investing involves risk of loss.
Affiliate disclosure: This site may contain affiliate links to brokerage platforms. If you open an account through one of our links, we may earn a commission at no additional cost to you. Affiliate relationships do not influence our editorial content or stock coverage decisions.